These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23903407)

  • 1. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.
    Thorek DL; Evans MJ; Carlsson SV; Ulmert D; Lilja H
    Thromb Haemost; 2013 Sep; 110(3):484-92. PubMed ID: 23903407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
    Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
    Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallikreins as biomarkers for prostate cancer.
    Hong SK
    Biomed Res Int; 2014; 2014():526341. PubMed ID: 24809052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells.
    Kollara A; Diamandis EP; Brown TJ
    J Steroid Biochem Mol Biol; 2003 Apr; 84(5):493-502. PubMed ID: 12767274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
    Magklara A; Scorilas A; Stephan C; Kristiansen GO; Hauptmann S; Jung K; Diamandis EP
    Urology; 2000 Sep; 56(3):527-32. PubMed ID: 10962338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate.
    Rittenhouse HG; Finlay JA; Mikolajczyk SD; Partin AW
    Crit Rev Clin Lab Sci; 1998 Aug; 35(4):275-368. PubMed ID: 9759557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
    Williams SA; Xu Y; De Marzo AM; Isaacs JT; Denmeade SR
    Prostate; 2010 May; 70(7):788-96. PubMed ID: 20058238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of sensitive immunoassays for free and total human glandular kallikrein 2.
    Väisänen V; Eriksson S; Ivaska KK; Lilja H; Nurmi M; Pettersson K
    Clin Chem; 2004 Sep; 50(9):1607-17. PubMed ID: 15247158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.
    Clements JA; Willemsen NM; Myers SA; Dong Y
    Crit Rev Clin Lab Sci; 2004; 41(3):265-312. PubMed ID: 15307634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus.
    Lawrence MG; Lai J; Clements JA
    Endocr Rev; 2010 Aug; 31(4):407-46. PubMed ID: 20103546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
    Becker C; Noldus J; Diamandis E; Lilja H
    Crit Rev Clin Lab Sci; 2001 Oct; 38(5):357-99. PubMed ID: 11720279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen and human glandular kallikrein: two kallikreins of the human prostate.
    Henttu P; Vihko P
    Ann Med; 1994 Jun; 26(3):157-64. PubMed ID: 7521173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
    Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
    Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen and new serum biomarkers for evaluation of chemopreventive agents.
    Partin AW; Marks LS
    Urology; 2001 Apr; 57(4 Suppl 1):132-6. PubMed ID: 11295611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
    Bonk S; Kluth M; Jansen K; Hube-Magg C; Makrypidi-Fraune G; Höflmayer D; Weidemann S; Möller K; Uhlig R; Büscheck F; Luebke AM; Burandt E; Clauditz TS; Steurer S; Schlomm T; Huland H; Heinzer H; Sauter G; Simon R; Dum D
    Prostate; 2020 Sep; 80(13):1097-1107. PubMed ID: 32628300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer marker.
    Darson MF; Pacelli A; Roche P; Rittenhouse HG; Wolfert RL; Young CY; Klee GG; Tindall DJ; Bostwick DG
    Urology; 1997 Jun; 49(6):857-62. PubMed ID: 9187691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.